Wyszukaj
Ogólne
wyszukiwanie
Dział kliniczny uniwersalne wyszukiwanie Dział przemysłowy uniwersalne wyszukiwanie
 

Search form

Co chcesz znaleźć?

Co chcesz znaleźć?
  • Nasze produkty
  • Nasze rozwiązania
Co chcesz znaleźć?
1 Wybierz
FRANCZYZĘ
2 Wybierz
ZASTOSOWANIE
3 Wybierz
PRODUKT

bioMérieux introduces EviSight™ Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production

06 październik, 2016

Marcy l’Etoile, France - October 6, 2016 – bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of EviSight™ Compact, an intelligent incubator system providing real time culture media reading. For use in pharmaceutical industry R&D and production settings, EviSight™ Compact combines incubation, intelligent automated detection and enumeration of colonies of bacteria, yeasts and molds in a single system. This launch results from bioMérieux’s acquisition of the company Advencis (Strasbourg-France) in October 2014.

Through kinetic reading, EviSight™ Compact’s high-magnification digital imaging technology provides every 30 minutes high resolution color images of the microbial cultures for colony detection.

Specific algorithms analyze every image and enable the detection of colonies at early growth stages, from a size as small as 30 microns. Openly configurable alert and action level settings allow to raise real time flagging of out of specification results thus saving production time. This new system provides highly reliable results for increased product safety and reduced costs for pharmaceutical companies.

The EviSight™ Compact platform is the first direct result from the synergies born from the recent acquisition of Advencis by bioMérieux. With an expertise of more than 25 years and a solid position of leadership in the field of industrial microbiological control, we are especially proud to provide our customers from pharmaceutical industry with this pioneering solution which enables rapid and intelligent identification of micro-organisms,” says Michaël Reynier, VP Health & Personal Care Business at bioMérieux. “This innovation further strengthens our portfolio of solutions for the pharmaceutical sector and illustrates our commitment to protecting consumers’ health”.

EviSight™ Compact works with ordinary ready-to-use plates and filters, allowing easy implementation and validation for the daily routine. Its embedded data processing system meets the increasing demand from the pharmaceutical industry for data integrity, traceability and reliability of quality control methods. This compact system can be used at each step of drug development and manufacturing, from the very first stage of R&D to finished products, including growth promotion test, environmental control, water testing and in-process sample testing. The system is scalable to up to 4 units connected to one computer for 6 to 12 plates per unit.

EviSight™ Compact will be progressively rolled out worldwide, starting in: France, the United-Kingdom, Germany, Austria, Switzerland, Italy, Benelux, the U.S., Canada and India.

Pobierz
Pioneering diagnostics